Matinas BioPharma | Investor Presentation Deck

Slide schematic 6/6

image 1/1 list 3/3 source-note 1/1 title 1/1

Components 6

photo bullet bullet bullet source-note headline

Tools 1

Problem Statement Canvas slide · 80%

list/bullet: IDSA Guidelines recommend treatment with mold-active azoles as first-line treatment for 6-12 weeks. Azole use requires fungal expertise to manage toxicities and significant DDIs that can limit duration of us

Metrics 0

∅

No metrics

No metric insight is anchored to this slide.

Frameworks 0

∅

No frameworks

No framework match is anchored to this slide.

Find anything

The slide highlights the limitations of current first-line azole treatments and identifies a specific patient sub-segment with high unmet need.